-
ISTA Pharmaceuticals Pushing on Daily Highs
Tuesday, July 12, 2011 - 1:56pm | 129Shares of ISTA Pharmaceuticals (NASDAQ: ISTA) are popping higher this afternoon and are testing the high of the day. Currently, shares are higher by 3.09%, trading at $8.00. ISTA Pharmaceuticals has been moving lower over the past two and a half months, but recently bounced around the 200-day...
-
Options Brief: Endo Pharmaceuticals
Tuesday, July 12, 2011 - 12:53pm | 71Shares of Endo Pharmaceuticals (NASDAQ: ENDP) are higher on the session by 0.10%, trading at $40.42. Overall put volume is now running at 4.57x the daily average, with 35% of all puts traded being purchases on the offer. 1,051 contracts have traded on the session so far. Endo Pharmaceuticals...
-
Tuesday's Put/Call Ratio Leaders
Tuesday, July 12, 2011 - 12:12pm | 76Here are today's Put/Call Ratio leaders… 1. Quest Diagnostics (NYSE: DGX) 2,541 puts, 21 call 2. KeyCorp (NYSE: KEY) 10,901 puts, 90 calls 3. Warner Chilcott (NASDAQ: WCRX) 2,590 puts, 22 calls 4. Ralcorp Holdings (NYSE: RAH) 3,188 puts, 35 calls 5. China Unicom (NYSE: CHU) 2,551 puts, 55 calls
-
Puts Purchased on Warner Chilcott
Tuesday, July 12, 2011 - 10:42am | 115Shares of Warner Chilcott (NASDAQ: WCRX) are higher on the session by 0.01%, currently trading at $24.01. The stock has been moving largely higher over the past five weeks and is currently trading above the 50-day moving average. Options traders are buying puts on the name today. A short while...
-
NASDAQ Stocks Hitting 52-Week Lows
Tuesday, July 12, 2011 - 10:21am | 138Spire Corporation (NASDAQ: SPIR) shares fell 0.87% to create a new 52-week low of $2.06. SPIR's trailing-twelve-month ROE is -38.94%. Manhattan Bridge Capital Inc (NASDAQ: LOAN) shares dropped 4.04% to create a new 52-week low of $1.21. LOAN shares have dropped 13.70% over the past 52 weeks, while...
-
Deutsche Bank Raises PT On VRX To $62
Tuesday, July 12, 2011 - 8:00am | 128Deutsche Bank, citing even further potential upside following a strong year, has raised its price target from $55 to $62 on Valeant Pharmaceuticals (NYSE: VRX) and maintains its Buy rating on the stock. Says Deutsche Bank, in its report, “Valeant shares have had an impressive run since the Biovail...
-
Zogenix to Develop and Commercialize Proprietary Long-Acting Risperidone Formulation for Needle-Free Subcutaneous Administration Using the DosePro Delivery System and DURECT's SABER Depot Technology
Tuesday, July 12, 2011 - 7:33am | 103Zogenix, Inc. (Nasdaq: ZGNX) and DURECT Corporation (Nasdaq: DRRX) announced today a development and license agreement. Under the agreement, Zogenix will be responsible for the clinical development and commercialization of a proprietary, long-acting injectable formulation of risperidone using...
-
J.P. Morgan Previews 2Q Results For JNJ
Tuesday, July 12, 2011 - 7:16am | 114J.P. Morgan is maintaining its Neutral rating and its $69 price target on Johnson & Johnson (NYSE: JNJ) in advance of the company's 2Q numbers, which are to be released one week from today. Says J.P. Morgan, in its report, “J&J will kick off 2Q earnings season when it reports next Tuesday...
-
Mylan Receives Voluntary License Rights to Gilead's HIV/AIDS Pipeline Products in Developing World
Tuesday, July 12, 2011 - 7:03am | 85Mylan Inc. (Nasdaq: MYL) today announced an expanded licensing agreement between Gilead Sciences Inc. and Mylan's Matrix Laboratories Limited. Matrix has licensed the rights to produce and market generic versions of three Gilead HIV/AIDS therapies, if and when they receive regulatory approval....
-
Twelve ETFs Trading Near 52-Week Highs
Tuesday, July 12, 2011 - 6:56am | 874First Trust Consumer Staples AlphaDEX (NYSE: FXG) is up more than 20% year to date. The investment seeks results that correspond generally to the price and yield of an equity index called the StrataQuant Consumer Staples Index. Top holdings include Green Mountain Coffee Roasters (NASDAQ: GMCR),...
-
Deutsche Bank Raises PT On Valeant Pharmaceuticals To $62
Tuesday, July 12, 2011 - 6:15am | 27Deutsche Bank has raised the price target on Valeant Pharmaceuticals (NYSE: VRX) from $55 to $62 and maintains its Buy rating.
-
10 High Yield, High Momentum Stocks
Tuesday, July 12, 2011 - 12:20am | 2859Once per month I run a high-yield dividend stock momentum screen and use the results to manage a hypothetical stock portfolio on Scott's Investments. The strategy did relatively well in 2010 and is one I continue to track because of its promise. In recent months I have also done a variation of...
-
Stock Market Ideas for Tuesday, July 12
Monday, July 11, 2011 - 5:53pm | 1481( click to enlarge ) This still looks pretty good on the daily chart with volume expanding as it moves higher. Coffee Holding Co., Inc. (NASDAQ:JVA) continues to look bullish and had a decent day today. The stock hit a high of $30.98, which is resistance for the next upside move. I'm buyer of...
-
Stocks to Watch for Tuesday 07/12/11: Fresh 52 Week Highs and Lows
Monday, July 11, 2011 - 5:09pm | 1546Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels. The following stocks hit new 52-week highs in Monday's trading session (listed from highest total volume to lowest): 1) BioSante Pharmaceuticals (NASDAQ: BPAX...
-
Duncan Williams Maintains Cadence Pharmaceuticals Strong Buy, $14 PT
Monday, July 11, 2011 - 3:08pm | 69Duncan Williams maintained its Cadence Pharmaceuticals (NASDAQ: CADX) Strong Buy rating and $14 price target in a research report published today. In the report, Duncan Williams states, "We have not yet seen any weakness in the vial sales and formulary approvals have exceeded our expectations."...